#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Young children’s accidental ingestion of cannabis edibles represents a growing poisoning risk that clinicians must recognize and screen for during pediatric evaluations, particularly given products that mimic candy packaging. Emergency providers need familiarity with cannabis toxidromes in pediatric patients to ensure appropriate triage and treatment, while primary care clinicians should counsel families on safe storage and educate parents about poisoning risks. This data highlights a critical public health gap in product safety regulation and packaging standards that clinicians can advocate for while managing acute poisonings and counseling families about household hazard mitigation.
A review of poison center calls in Wisconsin during 2025 revealed that cannabis exposures disproportionately affected pediatric populations, with 37% of reported poisonings involving children under age 5, primarily from ingestion of edible products. The predominance of young children in these cases suggests that current packaging and storage practices for cannabis edibles remain inadequate despite existing child-resistant container requirements, creating a significant public health vulnerability. This pattern mirrors historical trends with other household toxins and indicates that the rapid expansion of legalized cannabis markets may have outpaced the development of appropriate safeguards for homes with young children. Clinicians should counsel all patients with cannabis products in their homes about secure storage in locked containers kept out of reach of children, and be aware that cannabis poisoning in young children can present with altered mental status, respiratory depression, or seizures requiring supportive care. Parents and caregivers should also be educated that accidental pediatric cannabis exposures warrant evaluation at an emergency department or poison center, as symptoms may be delayed and dosing in children is unpredictable. Healthcare providers caring for families in states with legalized cannabis should routinely ask about edible products in the home during anticipatory guidance visits, treating this as part of standard injury prevention counseling for households with young children.
“When I see a child with accidental cannabis ingestion, what strikes me most is how preventable it is, yet how our current packaging and labeling standards still fall short of what we accept for pharmaceuticals or household chemicals—this gap tells me we need regulatory parity, not because cannabis is uniquely dangerous to children, but because we already know how to protect them and we’re choosing not to enforce those same standards consistently.”
⚠️ The significant representation of young children in cannabis poisoning cases reported to the Wisconsin Poison Center underscores an emerging public health concern in states with legalized cannabis products. While edible cannabis products are legally intended for adult consumers, their often appealing flavors, packaging, and appearance create substantial unintentional poisoning risk for young children who may access them in home settings. Clinicians should recognize that pediatric cannabis exposures typically present with drowsiness, altered mental status, or ataxia rather than the respiratory depression seen with opioid poisoning, yet serious effects including seizures and severe hypotension can occur at high doses. It is important to note that reported cases reflect only poisonings severe enough to prompt calls to poison control, likely underestimating true exposure frequency, and that individual severity varies considerably based on product potency, child weight, and time to decontamination. In practice, pediatric providers should
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: